Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07079306 · ClinicalTrials.gov registry record · NA
ChatGPT-Supported Text Messaging Program for Smoking Cessation
A NA study, sponsored by George Washington University.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07079306 is a NA study that has not yet begun recruiting, run by George Washington University. The registered enrollment target is 150 participants.
The verdict
NCT07079306, a NA study, has not yet begun recruiting, sponsored by George Washington University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Interventions
- BEHAVIORAL BeFree+Bot
- BEHAVIORAL BeFree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07079306
The ClinicalTrials.gov registry entry for NCT07079306 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BeFree+Bot is the first listed.
NCT07079306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07079306 about?
NCT07079306 is a clinical study titled "ChatGPT-Supported Text Messaging Program for Smoking Cessation". The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and B...
What is the current status of trial NCT07079306?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-10-01. Estimated completion is 2027-01-30.
What interventions are being tested in trial NCT07079306?
The interventions under investigation include: BeFree+Bot (BEHAVIORAL), BeFree (BEHAVIORAL).
Who is sponsoring clinical trial NCT07079306?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.